Kisha Mitchell-Richards

O-GlcNAc transferase suppresses necroptosis and liver fibrosis

Bichen Zhang, Min‐Dian Li, Ruonan Yin et al. · JCI Insight · 2019 · 89 citations · Full text

Life Sciences, Cell Biology, Molecular Medicine +17

Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506

Meenakshisundaram Ananthanarayanan, Jesús M. Bañales, Mateus T. Guerra et al. · Journal of Biological Chemistry · 2014 · 82 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Martin J. Edelman, Xiaofei Wang, Lydia Hodgson et al. · Journal of Clinical Oncology · 2017 · 81 citations

Medicine, Oncology, Pharmacology +16

Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.

Karyn A. Goodman, Donna Niedzwiecki, Nathan C. Hall et al. · Journal of Clinical Oncology · 2017 · 64 citations

Medicine, Nuclear Medicine, Radiation Oncology +16

Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5‐trisphosphate receptor

Tanaporn Khamphaya, Natsasi Chukijrungroat, Vitoon Saengsirisuwan et al. · Hepatology · 2017 · 64 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17